Dr. Kamalakannan Palanichamy is currently Assistant Professor of Radiation Oncology at The Ohio State University College of Medicine and Translational Therapeutics member of Comprehensive Cancer Center. He obtained his post-doctoral training at Harvard Medical School and his PhD from NIT, India. He and his group is also working to identify the underlying mechanisms of chemo and radiation resistance in treatment refractory tumors by short-circuiting signal transduction pathways and determining the mutational status, gene and molecular signatures mediating treatment resistance. His group has developed cancer stem cell models to investigate cancer stem cell biology via protein-protein interactions at translational and transcriptional levels. He has published over 50 papers with his research colleagues.
Dr. Kamalakannan Palanichamy research's focus is to bridge the gap between basic and clinical research. He works to explore transcriptomic, epigenetic, metabolomic, proteomic and genomic profiles in patient tumor biopsy samples to identify predictive and prognostic markers and validate therapeutic targets using pre-clinical models.